These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 24394117)

  • 41. [A Case of Locally Advanced and Metastatic Breast Cancer Treated with Preoperative Bevacizumab Combination Chemotherapy That Attained Local Control].
    Watanabe N; Furukawa J; Minoji T; Tamai K; Kitahara T; Yamamura N; Okamura S; Fukuchi N; Ebisui C; Yokouchi H; Kinuta M
    Gan To Kagaku Ryoho; 2018 Jul; 45(7):1097-1099. PubMed ID: 30042280
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Randomized Phase III Trial of Paclitaxel Once Per Week Compared With Nanoparticle Albumin-Bound Nab-Paclitaxel Once Per Week or Ixabepilone With Bevacizumab As First-Line Chemotherapy for Locally Recurrent or Metastatic Breast Cancer: CALGB 40502/NCCTG N063H (Alliance).
    Rugo HS; Barry WT; Moreno-Aspitia A; Lyss AP; Cirrincione C; Leung E; Mayer EL; Naughton M; Toppmeyer D; Carey LA; Perez EA; Hudis C; Winer EP
    J Clin Oncol; 2015 Jul; 33(21):2361-9. PubMed ID: 26056183
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Nab-paclitaxel-induced cystoid macular edema in a patient with pre-existing optic neuropathy.
    Park E; Goldberg NR; Adams S
    Anticancer Drugs; 2016 Jul; 27(6):580-4. PubMed ID: 26982237
    [TBL] [Abstract][Full Text] [Related]  

  • 44. nab-paclitaxel for the management of patients with advanced non-small-cell lung cancer.
    Hirsh V
    Expert Rev Anticancer Ther; 2014 Feb; 14(2):129-41. PubMed ID: 24467217
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Nanoparticle albumin-bound paclitaxel (nab-paclitaxel) as second-line chemotherapy in HER2-negative, taxane-pretreated metastatic breast cancer patients: prospective evaluation of activity, safety, and quality of life.
    Palumbo R; Sottotetti F; Trifirò G; Piazza E; Ferzi A; Gambaro A; Spinapolice EG; Pozzi E; Tagliaferri B; Teragni C; Bernardo A
    Drug Des Devel Ther; 2015; 9():2189-99. PubMed ID: 25931813
    [TBL] [Abstract][Full Text] [Related]  

  • 46. nab-Paclitaxel in combination with biologically targeted agents for early and metastatic breast cancer.
    Megerdichian C; Olimpiadi Y; Hurvitz SA
    Cancer Treat Rev; 2014 Jun; 40(5):614-25. PubMed ID: 24560997
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Peri-operative atrioventricular block as a result of chemotherapy with epirubicin and paclitaxel.
    Wheeler DW; Liew TV; Bailey AR
    Anaesthesia; 2007 Feb; 62(2):186-9. PubMed ID: 17223814
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [A patient with primary breast cancer who responded remarkably well to neoadjuvant chemotherapy with FEC100 followed by Abraxane].
    Yoshibayashi H; Ishiguro H; Kawaguchi K; Yamoto M; Nishimura T; Yamada H; Namura M; Nishio N; Nakamura K; Shimada K; Ono K; Kato H
    Gan To Kagaku Ryoho; 2013 May; 40(5):627-9. PubMed ID: 23863587
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The treatment patterns, efficacy, and safety of nab (®)-paclitaxel for the treatment of metastatic breast cancer in the United States: results from health insurance claims analysis.
    Liang C; Li L; Fraser CD; Ko A; Corzo D; Enger C; Patt D
    BMC Cancer; 2015 Dec; 15():1019. PubMed ID: 26714468
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [A Case of Drug-Induced Lung Injury Associated with Paclitaxel plus Bevacizumab Therapy].
    Yamaguchi Y; Tada Y; Takaya S; Iwamoto A; Yamashiro Y; Shibata S; Ishiguro M; Nishidoi H
    Gan To Kagaku Ryoho; 2016 Jun; 43(6):781-4. PubMed ID: 27306821
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Phase I study of nab-paclitaxel plus carboplatin and concurrent thoracic radiotherapy in patients with locally advanced non-small cell lung cancer.
    Kaira K; Tomizawa Y; Imai H; Sakurai R; Matsuura M; Yoshii A; Ochiai M; Kotake M; Ebara T; Saitoh JI; Sunaga N; Minato K; Saito R; Hisada T
    Cancer Chemother Pharmacol; 2017 Jan; 79(1):165-171. PubMed ID: 27995307
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A phase II study of weekly nanoparticle albumin-bound paclitaxel with or without trastuzumab in metastatic breast cancer.
    Mirtsching B; Cosgriff T; Harker G; Keaton M; Chidiac T; Min M
    Clin Breast Cancer; 2011 Apr; 11(2):121-8. PubMed ID: 21569998
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [A case of secondary sclerosing cholangitis caused by chemotherapy with nab-paclitaxel].
    Matsuo T; Nakamura Y; Suzuki K
    Nihon Shokakibyo Gakkai Zasshi; 2015 May; 112(5):888-95. PubMed ID: 25947025
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Paclitaxel and epirubicin followed by cyclophosphamide, methotrexate and 5-fluorouracil for patients with stage IIIC breast cancer with ten or more involved axillary lymph nodes.
    Battelli N; Massacesi C; Braconi C; Pilone A; Manzione L; Dinota A; Cobelli S; Scanni A; Sturba F; Giacomini G; Morale D; Giorgi F; Tummarello D; Cascinu S
    Am J Clin Oncol; 2006 Aug; 29(4):380-4. PubMed ID: 16891866
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Safety of nab-paclitaxel plus sunitinib: analysis of three cases.
    Dudek AZ; Nguyen S
    Anticancer Res; 2008; 28(5B):3099-105. PubMed ID: 19031964
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A dose-finding study of epirubicin in combination with paclitaxel in the treatment of advanced breast cancer.
    Conte PF; Michelotti A; Baldini E; Salvadori B; Gennari A; Da Prato M; Tibaldi C; Salzano E; Gentile A
    Semin Oncol; 1996 Oct; 23(5 Suppl 11):28-31. PubMed ID: 8893896
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Onychomadesis associated with chemotherapy: case report and mini literature review.
    Li A; Li Y; Ge L; Li P; Li W
    Drug Des Devel Ther; 2017; 11():2373-2376. PubMed ID: 28860708
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Phase III trial of epirubicin plus paclitaxel compared with epirubicin plus cyclophosphamide as first-line chemotherapy for metastatic breast cancer: United Kingdom National Cancer Research Institute trial AB01.
    Langley RE; Carmichael J; Jones AL; Cameron DA; Qian W; Uscinska B; Howell A; Parmar M
    J Clin Oncol; 2005 Nov; 23(33):8322-30. PubMed ID: 16293863
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A Phase I Study of Neoadjuvant Chemotherapy With Nab-Paclitaxel, Doxorubicin, and Cyclophosphamide in Patients With Stage II to III Breast Cancer.
    Werner TL; Ray A; Lamb JG; VanBrocklin M; Hueftle K; Cohen AL; Beck AC; Buys SS; Dyess DL; Butler TW; Dumlao TL; Neumayer L; Khong HT
    Clin Breast Cancer; 2017 Nov; 17(7):503-509. PubMed ID: 28579139
    [TBL] [Abstract][Full Text] [Related]  

  • 60. nab-paclitaxel: a novel formulation of taxane for treatment of breast cancer.
    Vishnu P; Roy V
    Womens Health (Lond); 2010 Jul; 6(4):495-506. PubMed ID: 20597612
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.